Cargando…
A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
Autores principales: | Sondhi, Anya K., Risso, Carla Barrientos, Taylor, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643940/ https://www.ncbi.nlm.nih.gov/pubmed/37969398 http://dx.doi.org/10.21037/tcr-23-1247 |
Ejemplares similares
-
Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)
por: Acharya, Utkarsh H., et al.
Publicado: (2020) -
Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
por: Petty, Amy J., et al.
Publicado: (2020) -
Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
por: Li, Jian, et al.
Publicado: (2018) -
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward
por: Jafarzadeh, Leila, et al.
Publicado: (2020) -
Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021)